Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.

Sparks, Jeffrey A; Krumme, Alexis A; Shrank, William H; Matlin, Olga S; Brill, Gregory; Pezalla, Edmund J; Choudhry, Niteesh K; Solomon, Daniel H

Sparks, Jeffrey A; Krumme, Alexis A; Shrank, William H; Matlin, Olga S; Brill, Gregory; Pezalla, Edmund J; Choudhry, Niteesh K; Solomon, Daniel H.

Afiliação

Sparks JA; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Krumme AA; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Shrank WH; CVS Health, Woonsocket, Rhode Island.
Matlin OS; CVS Health, Woonsocket, Rhode Island.
Brill G; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Pezalla EJ; Aetna, Hartford, Connecticut.
Choudhry NK; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Solomon DH; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Arthritis Rheumatol ; 68(7): 1588-95, 2016 07.

Article em En | MEDLINE | ID: mdl-26866506

Assuntos

Antirreumáticos/uso terapêutico; Artrite Reumatoide/tratamento farmacológico; Hidroxicloroquina/uso terapêutico; Metotrexato/uso terapêutico; Sulfassalazina/uso terapêutico; Adulto; Quimioterapia Combinada; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Fatores de Tempo; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sulfassalazina / Metotrexato / Antirreumáticos / Hidroxicloroquina Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google